Advaxis, Inc. (ADXS) Financials
ADXS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-10-31 | 7.0 million | 13.2 million |
2023-07-31 | 12.2 million | 11.1 million |
2023-04-30 | 21.0 million | 11.3 million |
2023-01-31 | 25.9 million | 2.3 million |
ADXS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-10-31 | -7.0 million | 89000 |
2023-07-31 | -7.0 million | 89000 |
2023-04-30 | -6.7 million | 1.2 million |
2023-01-31 | -2.8 million | 23000 |
ADXS Net Income
No data available :(
ADXS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-10-31 | 2.1 million | - | - |
2023-07-31 | 7.1 million | - | 1.4 million |
2023-04-30 | 16.8 million | - | 1.5 million |
2023-01-31 | 25.2 million | - | 1.7 million |
ADXS Shares Outstanding
ADXS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-10-31 | - | 5.7 million | 1.4 million | - |
2023-07-31 | - | 5.7 million | 2.8 million | - |
2023-04-30 | - | 7.3 million | 4.6 million | - |
2023-01-31 | 201000 | 2.2 million | 2.6 million | - |
ADXS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-10-31 | - | 7.1 million |
2023-07-31 | 9000 | 9000 |
2023-04-30 | 4000 | 4000 |
2023-01-31 | 250000 | 91000 |
ADXS
Price: $0.56
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.51 USD
P/E Ratio: -0.34
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 5364
Ebitda: -27.5 millionMarket Capitalization: 25.9 million